Franklin Liu

Statistics

Publications

Citations

2.5K

H-Index

Active since

1996

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Memorial Sloan Kettering Cancer Center

Diabetes Australia

Target (United States)

Franklin Liu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, signal transduction, and diabetes mellitus.

ORCID

Publications per year

1996–2019

Publications

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice

Alessandro Pocai, Paul E. Carrington, Jennifer R. Adams et al. · Diabetes · 2009 · 407 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance

Stacey Conarello, Zhihua Li, John Ronan et al. · Proceedings of the National Academy of Sciences · 2003 · 350 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy

Robert W. Myers, Hong-Ping Guan, Juliann Ehrhart et al. · Science · 2017 · 344 citations

Life Sciences, Biochemistry, Pharmacology +17

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1

Guoqiang Jiang, Zhihua Li, Franklin Liu et al. · Journal of Clinical Investigation · 2005 · 256 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1

Guoqiang Jiang, Zhihua Li, Franklin Liu et al. · Journal of Clinical Investigation · 2005 · 237 citations

Life Sciences, Biochemistry, Pharmacology +17

1–5 of 17